West Chester, PA, United States of America

Kenneth C McNulty


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007-2008

Loading Chart...
2 patents (USPTO):Explore Patents

As a client interested in inventor Kenneth C McNulty's noteworthy contributions to the field of innovation, it's fascinating to explore his journey in West Chester, Pennsylvania. Kenneth C McNulty's passion for innovation and his dedication to creating impactful solutions have solidified his reputation as a respected inventor in the region.

In his latest patents, Kenneth C McNulty has introduced groundbreaking processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and their intermediates. These innovations hold significant promise in treating corticotropin releasing factor (CRF)-related disorders such as anxiety and depression. Such inventions showcase his commitment to developing solutions that address critical medical needs.

With a total of two patents to his name, Kenneth C McNulty's career highlights underscore his relentless pursuit of excellence in the field of innovation. His work at Bristol-Myers Squibb Pharma Company has provided him with a platform to further his research and contribute meaningfully to the field.

In his professional journey, Kenneth C McNulty has had the privilege of collaborating with esteemed coworkers such as James P Sherbine and Shawn K Pack. These collaborations have not only enriched his own work but have also led to the development of novel ideas and solutions that have the potential to shape industries for years to come.

In conclusion, Kenneth C McNulty's innovative spirit, coupled with his dedication to creating solutions that make a difference, sets him apart as a visionary inventor in West Chester, Pennsylvania. His patents and collaborations reflect a career marked by excellence and a commitment to driving positive change through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…